PHARMACOECONOMICAL ASPECTS OF PARANOID SCHIZOPHRENIA TREATMENT USING COMBINED THERAPY WITH TYPICAL AND ATYPICAL NEUROLEPTICS

Ekaterina A Gordeeva; Nikita P Volkov; Nazim Ya Orudjev; Natalya A Chernaya; Maxim Yu Frolov

doi:10.17816/nb14128

Neurology Bulletin ›› 2018, Vol. L ›› Issue (2) : 107 -108. DOI: 10.17816/nb14128

Articles

brief-report

PHARMACOECONOMICAL ASPECTS OF PARANOID SCHIZOPHRENIA TREATMENT USING COMBINED THERAPY WITH TYPICAL AND ATYPICAL NEUROLEPTICS

Author information +

History +

PDF

Abstract

A “cost-effectiveness” analysis based on Markov modeling was conducted according to real clinical practice data. The aim was to evaluate clinical and economical aspects of using combined treatment with typical and atypical neuroleptics. Quality of life was assessed using QALY (quality-adjusted life-years). Transitions probabilities were based on time-to-event analysis.

Keywords

schizophrenia / the treatment of schizophrenia / cost-effectiveness analysis / Markov model

Cite this article

Download citation ▾

Ekaterina A Gordeeva, Nikita P Volkov, Nazim Ya Orudjev, Natalya A Chernaya, Maxim Yu Frolov. PHARMACOECONOMICAL ASPECTS OF PARANOID SCHIZOPHRENIA TREATMENT USING COMBINED THERAPY WITH TYPICAL AND ATYPICAL NEUROLEPTICS. Neurology Bulletin, 2018, L(2): 107-108 DOI:10.17816/nb14128

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Государственный реестр предельных отпускных цен. https://grls.rosminzdrav.ru/grls.aspx

[2]	Куликов А.Ю., Нгуен Т.Т., Тихомирова А.В. Методология моделирования в фармакоэкономике // Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. 2011. Т. 2. С. 8-16.

[3]	Менделевич В.Д. Клиническая и медицинская психология. М.: МЕДПРЕСС-информ, 2008. С. 123.

[4]	Ягудина Р.И., Серпик В.Г., Сороковиков И.В. Методологические основы анализа «затраты-эффективность»// Фармакоэкономика: теория и практика. 2014. Т. 2. С. 23-26

[5]	Briggs A. et al. Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: Direct utility elicitation Health Qual // Health and Quality of Life Outcomes. 2008. Vol. 6. pp. 1-9.

[6]	Filipovic-Pierucci A., Zarca K., Durand-Zaleski I. Markov Models For Health Economic Evaluation Modelling In R With The Heemod Package // Value in Health. 2018 Apr. Vol. 19, № 7. P. A369.